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with a diuretic [9]. Moreover, women are more proneMihatsch MJ, Nadasdy T, Nickerson P, Olsen TS, Papadimitriou
JC, Randhawa PS, Rayner DC, Roberts I, Rose S, Rush D, than men to develop diuretic-induced hyponatremia [10].
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tial cellular rejection in a HLA identical renal transplant: Impact density in the apical plasma membrane of the distal con-of donor microchimerism. Clinical Nephrology 48:300–306, 1997
voluted tubule in ovariectomized rats [11].
The clinical association between diuretic use or hyper-
tension and RCC has been corroborated by experimental
Diuretics and renal cell evidence. Hydrochlorothiazide is a cyclic imide that can
be converted in the stomach to a mutagenic nitroso deriv-
carcinoma—What is the ative [12]. Rats given hydrochlorothiazide developed de-
generative alterations including tumor markers and cellrisk/benefit ratio? death in the distal tubule [13]. Rats given diuretics devel-
oped nephropathy and renal adenoma. Since RCC origi-Renal cell carcinoma (RCC) is a frustrating tumor for
nates from the renal tubular cell, also the target of theclinicians to manage and treat. An increased risk for
diuretic’s pharmacologic effect, it is conceivable thatRCC occurs with smoking (which doubles the risk), obe-
chronic chemical bombardment of this cell for years maysity, hypertension, frequent consumption of fried meat
have a low-grade carcinogenic effect. Despite the wide-or poultry, and exposure to asbestos or petroleum prod-
spread use of diuretics in the USA, there are only aboutucts [1]. We recently found that long-term use of diuretics
16,000 new cases of RCC yearly, indicating a low risk.also increased the risk of RCC [2]. The association was
Most studies relating diuretics to RCC used medium toobserved in nine case-control studies and three cohort
high doses of diuretics. Moreover, despite our use ofstudies involving more than one million patients. The
association was stronger in women [odds ratio (OR) 2.01, diuretics for more than four decades, the possibility of
95% confidence interval (CI) 1.56–2.67] than in men low-grade carcinogenicity has emerged only recently.
(OR 1.69, 95% CI 1.34–2.13). In some studies the risk Thus, it seems that only prolonged exposure of medium
of RCC was related to the duration of the diuretic use to high doses of diuretic increases the risk of RCC. Since
[3–5]. It is possible that hypertension per se, and not we mainly use a low dose of hydrochlorothiazide at pres-
diuretic use, is associated with RCC. Indeed, in some ent, the overall risk for RCC seems to be low.
studies, the association between diuretic use and RCC We should define what is the true risk/benefit ratio of
became weaker after adjustment for the diagnosis of hy- diuretics, i.e. how many strokes and heart attacks do we
pertension [3, 5–7]. Shapiro et al reported that use of prevent while “causing” one RCC. A rough estimation
diuretics in women was associated with an odds ratio of showed that, in the general population, per one case of
1.8 for the development of RCC, but when adjusted for RCC, 17–30 strokes, 3–20 cardiovascular deaths and 4–18
a diagnosis of hypertension the odds ratio was only 1.1. deaths are prevented in the general population (abstract;[8]. For men, neither diuretic nor nondiuretic antihyper-
Messerli et al, Am J Hypertens 12:D104, 1999). In thetensive use was associated with RCC risk. Nonetheless,
elderly, in whom diuretics are particularly efficacious ina diagnosis of hypertension was clearly associated with
reducing cardiovascular events, the risk/benefit ratio isRCC risk for women only (OR 5 2.5, 95% CI 1.2–5.1).
even better, whereas in middle-aged women, for oneThus, the possibility that hypertension per se and not
case of RCC, only six strokes and no heart attacks ordiuretic use is a significant risk factor for RCC cannot
death are prevented. Thus, the elderly patient remainsbe ruled out entirely. However, arguing against this hy-
an excellent candidate for low-dose diuretic therapy be-pothesis are the facts that the association between di-
cause, in general, the elderly will not live long enoughuretic use and RCC remained significant after adjust-
to accumulate a significant carcinogenic risk with low-ment for the diagnosis of hypertension in 5 studies and
dose diuretic therapy. Also, in severe hypertension, con-that diuretic use also conferred a risk in normotensive
gestive heart failure, and other edematous states, diureticsubjects who took diuretics for other reasons.
The association between either hypertension or di- therapy should probably be combined, since its benefit
uretic use and RCC is stronger in women. The predomi- outweighs the risk. However, in younger or middle-aged
nance of diuretic- or hypertension-associated RCC in women who potentially will be exposed to antihyperten-
women was unexpected since RCC occurs about twice sive therapy for decades, the risk for diuretic associated-
RCC should be considered.
It is noteworthy that diuretics have the longest and
most thoroughly studied track record. In the absence of 1999 by the International Society of Nephrology
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a similar track record, no valid conclusion can be drawn Peritoneal elimination of
as to the comparative carcinogenicity (or absence thereof)
of other cardiovascular drugs. Therefore, the low-rate homocysteine moieties in
carcinogenicity of diuretic therapy should only serve as
a reminder to us practicing physicians that any drug continuous ambulatory
therapy has its inherent yet often unknown risks.
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